TEBENTAFUSP
Drug Details
- Generic Name
- TEBENTAFUSP
- Brand Names
- KIMMTRAK
- Application Number
- BLA761228
- Sponsor
- Immunocore Commercial LLC
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION, CONCENTRATE, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- TEBENTAFUSP
Indications and Usage
1 INDICATIONS AND USAGE KIMMTRAK is indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma. KIMMTRAK is a bispecific gp100 peptide-HLA-directed CD3 T cell engager indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma ( 1 , 2.1 ).